公司資料
Terns Pharmaceuticals 股價、新聞與催化劑
- 股票代碼:
- TERN
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
52.95 USD (+0.04%)
收盤價
最後更新: 2026年5月4日
6.12B USD
市值
股價為何變動
目前無法取得 TERN 的收盤價變動背景。
公司概覽
業務概覽
Terns Pharmaceuticals is a small-molecule biotech focused on oncology and metabolic disease opportunities. Its pipeline is built around targeted therapies with room for multiple shots on goal.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Terns sits in specialty biotechnology.
商業模式特徵
The company depends on clinical proof-of-concept, dose selection, and whether its pipeline can generate differentiated value.
生技產業定位
Terns is a high-beta development name whose stock reacts quickly to early clinical and strategic updates.
未來催化劑
- Terns Pharmaceuticals's catalysts are TERN-601 in obesity and TERN-701 in CML, the two programs that most directly determine whether the company has a real differentiated future. The market will care about whether either asset can keep the story moving.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。